Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids.

Blood
Alexey M ShibekoMikhail V Ovanesov

Abstract

Recombinant factor VIIa (rFVIIa) is used for treatment of hemophilia patients with inhibitors, as well for off-label treatment of severe bleeding in trauma and surgery. Effective bleeding control requires supraphysiological doses of rFVIIa, posing both high expense and uncertain thrombotic risk. Two major competing theories offer different explanations for the supraphysiological rFVIIa dosing requirement: (1) the need to overcome competition between FVIIa and FVII zymogen for tissue factor (TF) binding, and (2) a high-dose-requiring phospholipid-related pathway of FVIIa action. In the present study, we found experimental conditions in which both mechanisms contribute simultaneously and independently to rFVIIa-driven thrombin generation in FVII-deficient human plasma. From mathematical simulations of our model of FX activation, which were confirmed by thrombin-generation experiments, we conclude that the action of rFVIIa at pharmacologic doses is dominated by the TF-dependent pathway with a minor contribution from a phospholipid-dependent mechanism. We established a dose-response curve for rFVIIa that is useful to explain dosing strategies. In the present study, we present a pathway to reconcile the 2 major mechanisms of rFVIIa ...Continue Reading

References

Jun 1, 1994·Clinical Pharmacology and Therapeutics·C M LindleyH R Roberts
May 2, 1997·The Journal of Biological Chemistry·B B SorensenL V Rao
Apr 20, 2001·Seminars in Hematology·K C Anderson
Dec 6, 2001·Seminars in Hematology·M Hoffman, D M Monroe
Jan 25, 2002·Blood·Saulius ButenasKenneth G Mann
Jul 5, 2002·Blood·Maureane HoffmanHarold R Roberts
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Dougald M Monroe, Harold R Roberts
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Saulius ButenasKenneth G Mann
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·S ButenasK G Mann
Oct 1, 2004·Journal of Thrombosis and Haemostasis : JTH·C R M Hay
Oct 1, 2004·Journal of Thrombosis and Haemostasis : JTH·K Brummel ZiedinsK G Mann
Apr 7, 2005·Haemophilia : the Official Journal of the World Federation of Hemophilia·R ParameswaranUNKNOWN HTRS Registry Investigators
Jan 6, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Geoffrey A AllenAlisa S Wolberg
Mar 16, 2007·Journal of Thrombosis and Haemostasis : JTH·S Butenas, K G Mann
Sep 12, 2007·Annual Review of Medicine·Ulla Hedner, Mirella Ezban
May 23, 2008·Neurosurgery·Raj K NarayanUNKNOWN rFVIIa Traumatic ICH Study Group
Nov 13, 2008·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Mikhail V OvanesovFazoil I Ataullakhanov
Jul 14, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Saulius ButenasKenneth G Mann
Mar 2, 2010·Thrombosis Research·Maureane Hoffman, Dougald M Monroe
Mar 23, 2010·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Prosenjit SenL Vijaya Mohan Rao
May 15, 2010·Thrombosis Research·Mark N Levine
Aug 7, 2010·Drug Design, Development and Therapy·Pär I Johansson, Sisse R Ostrowski
Sep 10, 2010·Haemophilia : the Official Journal of the World Federation of Hemophilia·E BerntorpG Young
Dec 28, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hin Hin KoJenny Heathcote
Jan 26, 2011·International Journal of Surgery·Vikas GuptaJai Dev Wig
Feb 8, 2011·Journal of Thrombosis and Haemostasis : JTH·M HoffmanD M Monroe
Mar 25, 2011·Thrombosis Research·Ditte M KarpfHenning R Stennicke
Apr 20, 2011·Annals of Internal Medicine·Aaron C LoganRandall S Stafford
Apr 20, 2011·Annals of Internal Medicine·Veronica YankRandall S Stafford

❮ Previous
Next ❯

Citations

Jul 9, 2013·Thrombosis Journal·Yideng LiangMikhail V Ovanesov
Jul 15, 2015·European Journal of Haematology·Massimo Morfini
Nov 21, 2013·Haemophilia : the Official Journal of the World Federation of Hemophilia·H T T TranP A Holme
Jun 11, 2014·Journal of Thrombosis and Haemostasis : JTH·A M ShibekoM V Ovanesov
Dec 19, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·H T T TranP Andre Holme
Mar 31, 2016·American Journal of Veterinary Research·Erika J GruberTracy Stokol
Mar 15, 2014·Blood·Paris Margaritis
Jan 16, 2014·Blood·Dengmin FengDarrel W Stafford
Jul 28, 2012·Blood·Dougald M Monroe
Jun 9, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·G ChevreuxN Bihoreau
Dec 6, 2017·Therapeutic Advances in Hematology·Muriel Giansily-Blaizot, Jean-François Schved
Sep 29, 2018·Journal of Thrombosis and Haemostasis : JTH·A D ShapiroS Nasr
Aug 5, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·M WangJ-F Schved
Sep 12, 2019·Blood Advances·Wojciech JankowskiZuben E Sauna
Aug 20, 2019·Journal of Thrombosis and Haemostasis : JTH·Stephen FerrièrePeter J Lenting
May 3, 2020·Journal of Thrombosis and Haemostasis : JTH·Shiva KeshavaL Vijaya Mohan Rao
Feb 17, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·L A ParunovM V Ovanesov
Dec 7, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·Gurhan ErturanNicholas J Goddard
Sep 7, 2019·Haemophilia : the Official Journal of the World Federation of Hemophilia·Shannon L Meeks, Cindy A Leissinger
Jun 28, 2015·Briefings in Bioinformatics·Alexey M Shibeko, Mikhail A Panteleev
Feb 8, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Jerry GrandoniJean-Luc Plantier
Jun 22, 2021·Seminars in Thrombosis and Hemostasis·Julie Brogaard Larsen, Anne-Mette Hvas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.